Weiss Multi-Strategy Advisers’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29,996	Closed	-$331K	–	700
2022 Q2	$331K	Sell	29,996 -25,004	-45%	-$328K	0.01%	578
2022 Q1	$916K	Sell	55,000 -14,861	-21%	-$230K	0.02%	513
2021 Q4	$1.33M	Sell	69,861 -5,139	-7%	-$113K	0.03%	443
2021 Q3	$1.85M	Buy	75,000 +9,065	+14%	+$214K	0.04%	425
2021 Q2	$1.72M	Buy	65,935 +34,874	+112%	+$906K	0.04%	426
2021 Q1	$983K	Buy	31,061 +11,936	+62%	+$495K	0.02%	485
2020 Q4	$887K	Sell	19,125 -21,426	-53%	-$851K	0.02%	502
2020 Q3	$1.33M	Buy	40,551 +1,465	+4%	+$44.9K	0.04%	397
2020 Q2	$1.07M	Buy	39,086 +10,086	+35%	+$332K	0.03%	399
2020 Q1	$868K	Sell	29,000 -2,000	-6%	-$53K	0.03%	313
2019 Q4	$858K	Buy	31,000 +11,500	+59%	+$262K	0.02%	502
2019 Q3	$355K	Buy	+19,500	New	+$431K	0.01%	513